Sarah Hamidi
Assistant Professor · University of Texas M D Anderson Cancer Center
Credentials: · ·
History
- 2020–2022
- 2017–2020
- 2013–2017
Doctor of Medicine
Research
Thyroid · 2024 · First of 9 authors · 75 citations
Toxicity in the era of immune checkpoint inhibitor therapy
Review · Frontiers in Immunology · 2024 · 61 citations
Review · Frontiers in Endocrinology · 2023 · First of 7 authors · 42 citations
23 papers
22 papers
19 papers
19 papers
18 papers
17 papers
17 papers
15 papers
Clinical trials
- 2026–2032
Zanzalintinib Plus Cemiplimab for the Treatment of BRAF Wild-Type Anaplastic Thyroid Cancer
Principal investigator · Not yet recruiting · Phase 2
M.D. Anderson Cancer Center